Genetic analysis of attenuation markers of cold-adapted X-31 influenza live vaccine donor strain

Vaccine

Volumn 34, Issue 11, 2016, Pages 1343-1349

  Jang, Yo Han ^a   Jung, Eun Ju ^a   Lee, Kwang Hee ^a   Byun, Young Ho ^a   Yang, Seung Won ^a   Seong, Baik Lin ^a  

^a Yonsei University   (South Korea)

Author keywords

Cold adapted live vaccine; Influenza virus; Nucleoprotein; Phenotype; X 31

Indexed keywords

COLD ADAPTED X 31 LIVE ATTENUATED INFLUENZA VACCINE; INFLUENZA VACCINE; UNCLASSIFIED DRUG; LIVE VACCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GENETIC ANALYSIS; GENETIC MARKER; GENETIC REASSORTMENT; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLUENZA; INFLUENZA A VIRUS (H1N1); MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STRUCTURAL GENE; VIRUS GENE; VIRUS VIRULENCE; ADAPTATION; AMINO ACID SUBSTITUTION; ANIMAL; BAGG ALBINO MOUSE; COLD; DOG; GENETICS; HEK293 CELL LINE; INFLUENZA A VIRUS; MDCK CELL LINE; SEQUENCE ALIGNMENT; VIRAL PLAQUE ASSAY;

ADAPTATION, BIOLOGICAL; AMINO ACID SUBSTITUTION; ANIMALS; COLD TEMPERATURE; DOGS; FEMALE; HEK293 CELLS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MADIN DARBY CANINE KIDNEY CELLS; MICE; MICE, INBRED BALB C; PHENOTYPE; REASSORTANT VIRUSES; SEQUENCE ALIGNMENT; VACCINES, ATTENUATED; VIRAL PLAQUE ASSAY;

EID: 84959150699     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.01.053     Document Type: Article

References (32)

1. Simonsen L., Clarke M.J., Williamson G.D., Stroup D.F., Arden N.H., Schonberger L.B. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997, 87:1944-1950.
2. Simonsen L., Fukuda K., Schonberger L.B., Cox N.J. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000, 181:831-837.
3. Jin H., Subbarao K. Live attenuated influenza vaccine. Curr Top Microbiol Immunol 2015, 386:181-204.
4. Jang Y.H., Seong B.L. Cross-protective immune responses elicited by live attenuated influenza vaccines. Yonsei Med J 2013, 54:271-282.
5. Murphy B.R., Coelingh K. Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines. Viral Immunol 2002, 15:295-323.
6. Jang Y.H., Seong B.L. Principles underlying rational design of live attenuated influenza vaccines. Clin Exp Vaccine Res 2012, 1:35-49.
7. Cox R.J., Brokstad K.A., Ogra P. Influenza virus: immunity and vaccination strategies, comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 2004, 59:1-15.
8. Nichol K.L., Treanor J.J. Vaccines for seasonal and pandemic influenza. J Infect Dis 2006, 194(Suppl 2):S111-S118.
9. Herlocher M.L., Maassab H.F., Webster R.G. Molecular and biological changes in the cold-adapted master strain A/AA/6/60 (H2N2) influenza virus. Proc Natl Acad Sci USA 1993, 90:6032-6036.
10. Chen Z., Aspelund A., Kemble G., Jin H. Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist). Virology 2006, 345:416-423.
11. Snyder M.H., Betts R.F., DeBorde D., Tierney E.L., Clements M.L., Herrington D., et al. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J Virol 1988, 62:488-495.
12. Isakova-Sivak I., Chen L-M., Matsuoka Y., Voeten J.T.M., Kiseleva I., Heldens J.G.M., et al. Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). Virology 2011, 412:297-305.
13. Kiseleva I.V., Voeten J.T., Teley L.C., Larionova N.V., Drieszen-van der Cruijsen S.K., Basten S.M., et al. PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus. J Gen Virol 2010, 91:931-937.
14. Hoffmann E., Mahmood K., Chen Z., Yang C.F., Spaete J., Greenberg H.B., et al. Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66. J Virol 2005, 79:11014-11021.
15. Donabedian A.M., DeBorde D.C., Maassab H.F. Genetics of cold-adapted B/Ann Arbor/1/66 influenza virus reassortants: the acidic polymerase (PA) protein gene confers temperature sensitivity and attenuated virulence. Microb Pathog 1987, 3:97-108.
16. Donabedian A.M., DeBorde D.C., Cook S., Smitka C.W., Maassab H.F. A mutation in the PA protein gene of cold-adapted B/Ann Arbor/1/66 influenza virus associated with reversion of temperature sensitivity and attenuated virulence. Virology 1988, 163:444-451.
17. Lee K.H., Seo S.U., Song J.M., Lee C.M., Kim H.A., Seong B.L. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus. Vaccine 2006, 24:1966-1974.
18. Jang Y.H., Lee E.Y., Byun Y.H., Jung E.J., Lee Y.J., Lee Y.H., et al. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains. Vaccine 2014, 32:535-543.
19. Jang Y.H., Jung E.J., Byun Y.H., Lee K.H., Lee E.Y., Lee Y.J., et al. Immunogenicity and protective efficacy of cold-adapted X-31 live attenuated pre-pandemic H5N1 influenza vaccines. Vaccine 2013, 31:3339-3346.
20. Jang Y.H., Byun Y.H., Lee D.H., Lee K.H., Lee Y.J., Lee Y.H., et al. Cold-adapted X-31 live attenuated 2009 pandemic H1N1 influenza vaccine elicits protective immune responses in mice and ferrets. Vaccine 2013, 31:1320-1327.
21. Jang Y.H., Byun Y.H., Lee Y.J., Lee Y.H., Lee K.H., Seong B.L. Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses. J Virol 2012, 86:5953-5958.
22. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 2000, 97:6108-6113.
23. Jung E.J., Lee K.H., Seong B.L. Reverse genetic platform for inactivated and live-attenuated influenza vaccine. Exp Mol Med 2010, 42:116-121.
24. Baez M., Palese P., Kilbourne E.D. Gene composition of high-yielding influenza vaccine strains obtained by recombination. J Infect Dis 1980, 141:362-365.
25. Cox N.J., Kitame F., Kendal A.P., Maassab H.F., Naeve C. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). Virology 1988, 167:554-567.
26. Klimov A.I., Cox N.J., Yotov W.V., Rocha E., Alexandrova G.I., Kendal A.P. Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus. Virology 1992, 186:795-797.
27. Jin H., Lu B., Zhou H., Ma C., Zhao J., Yang C.F., et al. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology 2003, 306:18-24.
28. Klimov A.I., Kiseleva I.V., Alexandrova G.I., Cox N.J. Genes coding for polymerase proteins are essential for attenuation of the cold-adapted A/Leningrad/134/17/57 (H2N2) influenza virus. Int Congr Series 2001, 1219:955-959.
29. Biswas S.K., Boutz P.L., Nayak D.P. Influenza virus nucleoprotein interacts with influenza virus polymerase proteins. J Virol 1998, 72:5493-5501.
30. Poole E., Elton D., Medcalf L., Digard P. Functional domains of the influenza A virus PB2 protein: identification of NP- and PB1-binding sites. Virology 2004, 321:120-133.
31. Klumpp K., Ruigrok R.W., Baudin F. Roles of the influenza virus polymerase and nucleoprotein in forming a functional RNP structure. EMBO J 1997, 16:1248-1257.
32. Lee K.H., Youn J.W., Kim H.J., Seong B.L. Identification and characterization of mutations in the high growth vaccine strain of influenza virus. Arch Virol 2001, 146:369-377.